by jlohrconsulting | Oct 2, 2025 | Uncategorized
PNAS Nexus. 2025 Sep 18;4(10):pgaf302. doi: 10.1093/pnasnexus/pgaf302. eCollection 2025 Oct. ABSTRACT The cerebellum has been considered to perform error-based supervised learning via long-term depression (LTD) at synapses between parallel fibers and Purkinje cells...
by jlohrconsulting | Oct 2, 2025 | Uncategorized
Head Neck. 2025 Oct 2. doi: 10.1002/hed.70059. Online ahead of print. ABSTRACT BACKGROUND: Understanding quality of life (QOL) after head and neck cancer (HNC) is crucial for service planning. This study explored survivorship experiences in New Zealand. METHODS: This...
by jlohrconsulting | Oct 2, 2025 | Uncategorized
Int J Eat Disord. 2025 Oct 2. doi: 10.1002/eat.24525. Online ahead of print. ABSTRACT OBJECTIVE: Illness duration has been examined as a predictor of anorexia nervosa (AN) outcomes to mixed results, yet is frequently used to make treatment and prognosis decisions....
by jlohrconsulting | Oct 2, 2025 | Uncategorized
Front Psychiatry. 2025 Sep 16;16:1623166. doi: 10.3389/fpsyt.2025.1623166. eCollection 2025. ABSTRACT There is increasing recognition of phenomenological approaches to understanding anorexia nervosa (AN), interrogating lived experiences and voices of those diagnosed...
by jlohrconsulting | Oct 2, 2025 | Uncategorized
Front Neurol. 2025 Sep 16;16:1638549. doi: 10.3389/fneur.2025.1638549. eCollection 2025. ABSTRACT BACKGROUND: Glucose transporter type 1 deficiency syndrome (Glut1DS) is a treatable neurogenetic metabolic disorder caused by pathogenic variants in the SLC2A1 gene. The...
Recent Comments